Skip to main content

Notice of completed evaluations - 22 December 2022

We have published 17 evaluations about the human health and environmental risks associated with the use of certain chemicals on the Australian Inventory of Industrial Chemicals (Inventory).

These evaluation statements are issued by the AICIS Executive Director under the Industrial Chemicals Act 2019, Section 78 and are listed below. The draft versions of these evaluation statements were open for public consultation that closed on 7 December 2022. 

The evaluation of 1-methoxy-4-(2-propenyl)benzene (estragole) (EVA00091) has not been finalised at this time to allow further consideration of information submitted as part of the public consultation process. 

Note: Use the scroll bar located at the bottom of the table if you're viewing on a smaller screen or mobile device. 

Evaluation ID

Subject of evaluation

Public comment received

Public consultation outcome

Evaluation outcome

EVA00022

Octanamide, N-Hydroxy-

No

-

Recommendation to regulatory body (workers); Information relating to safe introduction and use

EVA00040

Musk tibetene and a structural analogue

No

-

Proposal to vary terms of the inventory

EVA00055

Benzene, 1,2,3,4,5-pentachloro- (PeCB)

Yes - exposure and hazard information

A variation to the evaluation statement was required. The evaluation statement has been amended to explain health hazard information.

Proposal to remove a chemical from the inventory; Recommendation to regulatory body (environment)

EVA00056

Benzene, hexachloro- (HCB)

No

-

Proposal to remove a chemical from the inventory; Recommendation to regulatory body (environment)

EVA00060

Carbamic acid, 1H-benzimidazol-2-yl-, methyl ester (carbendazim)

Yes – exposure and hazard information; editorial/factual; other

A variation to the evaluation statement was required due to new information becoming available. The evaluation statement has been amended to:

  • indicate the low risk of skin sensitisation to end users at specified concentrations
  • clarify the role of impurities on the potential genotoxic effects of the chemical
  • add study references relating to the chemical leaching from painted surfaces and plastic membranes into soil and stormwater.

Recommendation to regulatory body (public health); Recommendation to regulatory body (workers); Recommendation to regulatory body (environment); Information relating to safe introduction and use

EVA00090

1-bromo-3-chloropropane and 1,3-dibromopropane

No

-

Recommendation to regulatory body (workers); Information relating to safe introduction and use

EVA00092

2-Propenamide, 2-methyl- (methacrylamide)

No

-

Recommendation to regulatory body (workers); Information relating to safe introduction and use

EVA00094

Chemicals that are unlikely to require further regulation to manage risks to environment

No

-

No new means of managing risk are proposed

EVA00095

Chemicals that are unlikely to require further regulation to manage risks to human health

No

-

No new means of managing risk are proposed

EVA00100

Use of aluminium in antiperspirants

No

-

No new means of managing risk are proposed

EVA00101

Polymers incorporating glycidyl methacrylate

No

-

No new means of managing risk are proposed

EVA00106

Hydroquinone and p-benzoquinone

No

-

No new means of managing risk are proposed

EVA00107

Cadmium sulfide pigments

No

-

No new means of managing risk are proposed

EVA00110

Glyoxylic acid

No

-

Recommendation to regulatory body (public health); Recommendation to regulatory body (workers); Information relating to safe introduction and use

EVA00112

Carbamic acid, butyl-, 3-iodo-2-propynyl ester (IPBC)

No

-

No new means of managing risk are proposed

EVA00114

Long chain (C≥10) alkyl benzene sulfonates

No

-

Recommendation to regulatory body (workers); Information relating to safe introduction and use

EVA00116

Lauryl (dodecyl) sulfates

No

-

No new means of managing risk are proposed

 

Published date
Was this page helpful?
For broken links or technical issues, please provide as much detail as possible. Do not include your name, email address and other personal or commercially sensitive information.

Keep informed with updates